BiotechTube
Home/FIMECS/Kanae Gamo, Ph.D.
KG

Kanae Gamo, Ph.D.

Chief Executive Officer

FIMECS

Therapeutic Areas

Oncology

FIMECS Pipeline

DrugIndicationPhase
FIM-001Non-small cell lung cancer, Pancreatic cancerDiscovery
TRIB1 degraderAcute myeloid leukemiaDiscovery
Undisclosed program 1OncologyDiscovery
Undisclosed program 2OncologyDiscovery

Leadership Team at FIMECS

KA
Kazuteru Aoki, Ph.D.
Chief Scientific Officer
View full FIMECS profile